Literature DB >> 23055368

Management of pain in Parkinson's disease.

Munazza Sophie1, Blair Ford.   

Abstract

Pain is a common symptom in Parkinson's disease (PD) and accounts for substantial morbidity in up to 80 % of patients. Despite contributing to disease-related discomfort and disability, pain in PD frequently goes underacknowledged and undertreated in clinical practice. Although the exact underlying neurophysiology is unclear, there is increasing understanding of the role of the basal ganglia in somatosensory processing, as well as involvement of additional brainstem structures and non-dopaminergic pathways; appreciation of these mechanisms has implications for treatment strategies. Categorizing painful symptoms based on their clinical description into musculoskeletal, dystonic, radicular-peripheral neuropathic and central pain categories provides a useful framework for management. Importantly, these symptoms should be evaluated in relation to motor symptoms and dopaminergic therapy. A multi-disciplinary approach is recommended as follows: physical therapy, liaison with pain management and consultations to rheumatological, orthopaedic and neurosurgical services should be considered.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23055368     DOI: 10.1007/s40263-012-0005-2

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  120 in total

1.  Use of complementary and alternative therapies in outpatients with Parkinson's disease in Argentina.

Authors:  Cristina Pecci; Maria J Rivas; Carolina M Moretti; Gabriela Raina; Carlos Zúñiga Ramirez; Sergio Díaz; Claudia Uribe Roca; Federico E Micheli
Journal:  Mov Disord       Date:  2010-10-15       Impact factor: 10.338

2.  Effect of deep brain subthalamic stimulation on camptocormia and postural abnormalities in idiopathic Parkinson's disease.

Authors:  Mark A Hellmann; Ruth Djaldetti; Zvi Israel; Eldad Melamed
Journal:  Mov Disord       Date:  2006-11       Impact factor: 10.338

3.  Back problems in Parkinson's disease: an underestimated problem.

Authors:  Fabien Etchepare; Sylvie Rozenberg; Tristan Mirault; Anne-Marie Bonnet; Colette Lecorre; Yves Agid; Pierre Bourgeois; Bruno Fautrel
Journal:  Joint Bone Spine       Date:  2005-11-15       Impact factor: 4.929

4.  Parkinson's disease symptoms: the patient's perspective.

Authors:  Marios Politis; Kit Wu; Sophie Molloy; Peter G Bain; K Ray Chaudhuri; Paola Piccini
Journal:  Mov Disord       Date:  2010-08-15       Impact factor: 10.338

5.  L-Dopa decreases cutaneous nociceptive inhibition of motor activity in Parkinson's disease.

Authors:  M Serrao; L Parisi; G Valente; A Martini; F Fattapposta; F Pierelli; P Rossi
Journal:  Acta Neurol Scand       Date:  2002-03       Impact factor: 3.209

6.  Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.

Authors:  Valerie C Anderson; Kim J Burchiel; Penelope Hogarth; Jacques Favre; John P Hammerstad
Journal:  Arch Neurol       Date:  2005-04

7.  Oral and genital pain syndromes in Parkinson's disease.

Authors:  B Ford; E D Louis; P Greene; S Fahn
Journal:  Mov Disord       Date:  1996-07       Impact factor: 10.338

Review 8.  Neurotransmission in Parkinson's disease: beyond dopamine.

Authors:  P Barone
Journal:  Eur J Neurol       Date:  2009-12-30       Impact factor: 6.089

9.  Controlled release levodopa-carbidopa (CR-5) in the management of parkinsonian motor fluctuations.

Authors:  J L Juncos; G Fabbrini; M M Mouradian; T N Chase
Journal:  Arch Neurol       Date:  1987-10

10.  Quantitative measurement of pain sensation in patients with Parkinson disease.

Authors:  R Djaldetti; A Shifrin; Z Rogowski; E Sprecher; E Melamed; D Yarnitsky
Journal:  Neurology       Date:  2004-06-22       Impact factor: 9.910

View more
  17 in total

1.  Relief of Pain-Depressed Behavior in Rats by Activation of D1-Like Dopamine Receptors.

Authors:  Matthew F Lazenka; Kelen C Freitas; Sydney Henck; S Stevens Negus
Journal:  J Pharmacol Exp Ther       Date:  2017-04-14       Impact factor: 4.030

Review 2.  Therapeutic potential of targeting glutamate receptors in Parkinson's disease.

Authors:  Clare Finlay; Susan Duty
Journal:  J Neural Transm (Vienna)       Date:  2014-02-21       Impact factor: 3.575

Review 3.  Modulation of pain, nociception, and analgesia by the brain reward center.

Authors:  Vasiliki Mitsi; Venetia Zachariou
Journal:  Neuroscience       Date:  2016-05-14       Impact factor: 3.590

4.  Loss of dopamine D1 receptors and diminished D1/5 receptor-mediated ERK phosphorylation in the periaqueductal gray after spinal cord lesion.

Authors:  Pamela J Voulalas; Yadong Ji; Li Jiang; Jamila Asgar; Jin Y Ro; Radi Masri
Journal:  Neuroscience       Date:  2016-12-05       Impact factor: 3.590

Review 5.  Treatment of advanced Parkinson's disease.

Authors:  Juan C Giugni; Michael S Okun
Journal:  Curr Opin Neurol       Date:  2014-08       Impact factor: 5.710

Review 6.  Management of motor and non-motor symptoms in Parkinson's disease.

Authors:  Fabienne Sprenger; Werner Poewe
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

Review 7.  Potential for Kappa-Opioid Receptor Agonists to Engineer Nonaddictive Analgesics: A Narrative Review.

Authors:  Shane W Kaski; Allison N White; Joshua D Gross; David P Siderovski
Journal:  Anesth Analg       Date:  2021-02-01       Impact factor: 6.627

Review 8.  The Rationale for Exercise in the Management of Pain in Parkinson's Disease.

Authors:  Natalie E Allen; Niamh Moloney; Vanessa van Vliet; Colleen G Canning
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

Review 9.  Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.

Authors:  Mariana Babayeva; Haregewein Assefa; Paramita Basu; Sanjeda Chumki; Zvi Loewy
Journal:  Parkinsons Dis       Date:  2016-12-05

10.  A Meta-Analysis of the Effect of Subthalamic Nucleus-Deep Brain Stimulation in Parkinson's Disease-Related Pain.

Authors:  Yu Diao; Yutong Bai; Tianqi Hu; Zixiao Yin; Huangguang Liu; Fangang Meng; Anchao Yang; Jianguo Zhang
Journal:  Front Hum Neurosci       Date:  2021-07-01       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.